Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neema Mturi

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Wellcome Open Research|May 6, 2024
Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trialMainga Hamaluba, Samuel Sang, Benedict Orindi, et al.
Science Advances|September 14, 2019
The ferroportin Q248H mutation protects from anemia, but not malaria or bacteremiaJohn Muthii Muriuki, Alexander J Mentzer, Gavin Band, et al.
American Journal of Human Genetics|May 31, 2016
Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children, , Anna Rautanen, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Wellcome Open Research|May 6, 2024
Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trialMainga Hamaluba, Samuel Sang, Benedict Orindi, et al.
Science Advances|September 14, 2019
The ferroportin Q248H mutation protects from anemia, but not malaria or bacteremiaJohn Muthii Muriuki, Alexander J Mentzer, Gavin Band, et al.
American Journal of Human Genetics|May 31, 2016
Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children, , Anna Rautanen, et al.
Pageof 7